Source,Relationship,Target,Reason,Evidence URL,Evidence Text
olema.com,partner_of,Ooma,The investigated page is an Ooma 'Partners - Reseller' page describing its reseller partner program and how resellers can sell Ooma solutions; this indicates Ooma offers a reseller partnership relationship.,https://www.ooma.com/partners/resellers/?srsltid=AfmBOooh7Hiau--RjHqCYL5qgvZildUJ_GsVD-gpe4I9o-YsQOeYUaYM,"""Resellers Guide customers to the business solutions that deliver enterprise-grade communications at a small business price."" / ""Reseller partners have the option of full ownership of billing and support."""
olema.com,partner_of,McKesson,The page states Olema Oncology will leverage major specialty distributors like McKesson as distributor partners for specialty pharmaceutical distribution.,https://portersfiveforce.com/blogs/marketing-strategy/olema,"""For broader reach into community hospitals, Olema Oncology will leverage major specialty distributors like McKesson and AmerisourceBergen. These partners already handle over 60% of U.S. specialty pharmaceutical distribution"""
olema.com,partner_of,AmerisourceBergen,The page lists AmerisourceBergen as a major specialty distributor partner Olema Oncology will leverage for distribution.,https://portersfiveforce.com/blogs/marketing-strategy/olema,"""For broader reach into community hospitals, Olema Oncology will leverage major specialty distributors like McKesson and AmerisourceBergen."""
olema.com,uses,Doximity,The page says Olema Oncology targets oncologists using digital platforms like Doximity as part of its marketing strategy.,https://portersfiveforce.com/blogs/marketing-strategy/olema,"""digital targeting on platforms like Doximity and LinkedIn"""
olema.com,uses,LinkedIn,The page states Olema Oncology uses LinkedIn for digital targeting in its marketing strategy.,https://portersfiveforce.com/blogs/marketing-strategy/olema,"""digital targeting on platforms like Doximity and LinkedIn"""
olema.com,uses,Veeva,The page indicates Olema likely uses a Veeva-powered CRM system for HCP segmentation and engagement.,https://portersfiveforce.com/blogs/marketing-strategy/olema,"""A likely Veeva-powered CRM system enables precise segmentation of HCPs"""
olema.com,partner_of,ASCO,"The page references Olema Oncology content/marketing anchored by data cuts from major congresses like ASCO, implying participation/engagement with ASCO congress as a channel.",https://portersfiveforce.com/blogs/marketing-strategy/olema,"""data cuts from major congresses like ASCO and SABCS"""
olema.com,partner_of,SABCS,"The page references Olema Oncology content anchored by data from congresses like SABCS, implying engagement with SABCS as a key conference channel.",https://portersfiveforce.com/blogs/marketing-strategy/olema,"""data cuts from major congresses like ASCO and SABCS"""
olema.com,client_of,Silicon Valley Bank,"Preqin profile states Olema Pharmaceuticals raised venture debt financing led by Silicon Valley Bank, indicating Olema is a financing client/borrower of SVB.",https://www.preqin.com/data/profile/asset/olema-pharmaceuticals--inc-/384603,"""raising USD 50.00 mn through a VENTURE DEBT financing led by Silicon Valley Bank"""
olema.com,uses,Nasdaq,"Preqin profile states Olema raised funds via an IPO selling shares on Nasdaq, indicating it uses Nasdaq as its listing/exchange venue.",https://www.preqin.com/data/profile/asset/olema-pharmaceuticals--inc-/384603,"""raised USD 209.00 mn ... on Nasdaq in November 2020"""
olema.com,partner_of,Foresite Capital,"Preqin profile lists Foresite Capital as a current investor in Olema Pharmaceuticals, indicating an investment relationship.",https://www.preqin.com/data/profile/asset/olema-pharmaceuticals--inc-/384603,"""Current Investors\n\nForesite Capital, BVF Partners, RA Capital Management"""
olema.com,partner_of,BVF Partners,"Preqin profile lists BVF Partners as a current investor in Olema Pharmaceuticals, indicating an investment relationship.",https://www.preqin.com/data/profile/asset/olema-pharmaceuticals--inc-/384603,"""Current Investors\n\nForesite Capital, BVF Partners, RA Capital Management"""
olema.com,partner_of,RA Capital Management,"Preqin profile lists RA Capital Management as a current investor in Olema Pharmaceuticals, indicating an investment relationship.",https://www.preqin.com/data/profile/asset/olema-pharmaceuticals--inc-/384603,"""Current Investors\n\nForesite Capital, BVF Partners, RA Capital Management"""
olema.com,partner_of,Novartis,MatrixBCG page states Olema Oncology has a strategic alliance with Novartis for palazestrant and that Novartis supplies drug material; also notes OPERA-02 trial investigates palazestrant in combination with Novartis’s Kisqali (ribociclib).,https://matrixbcg.com/products/olema-business-model-canvas,"""Olema Oncology's strategic alliance with Novartis for its lead candidate, palazestrant... vital for the pivotal Phase 3 OPERA-02 trial, investigating palazestrant in combination with Novartis's Kisqali... Novartis's commitment to supplying the necessary drug material"""
olema.com,uses,U.S. Food and Drug Administration (FDA),Page describes regulatory engagement and milestones (Fast Track designation and IND clearance) with the FDA for Olema drug candidates.,https://matrixbcg.com/products/olema-business-model-canvas,"""Regulatory bodies, such as the U.S. Food and Drug Administration (FDA)... Achieving key milestones like Fast Track designation for palazestrant and Investigational New Drug (IND) clearance for OP-3136"""
olema.com,partner_of,American Association for Cancer Research (AACR),Page lists AACR as a major conference channel where Olema presents research findings to the scientific community.,https://matrixbcg.com/products/olema-business-model-canvas,"""presentations at major oncology conferences such as the American Association for Cancer Research (AACR) and the European Society for Medical Oncology (ESMO)"""
olema.com,partner_of,European Society for Medical Oncology (ESMO),Page lists ESMO as a major conference channel where Olema presents research findings to the scientific community.,https://matrixbcg.com/products/olema-business-model-canvas,"""presentations at major oncology conferences such as the American Association for Cancer Research (AACR) and the European Society for Medical Oncology (ESMO)"""
olema.com,partner_of,GlobeNewswire,Page states Olema uses financial news services like GlobeNewswire to distribute announcements to the investment community.,https://matrixbcg.com/products/olema-business-model-canvas,"""utilizes prominent financial news services like GlobeNewswire and BioSpace to ensure broad reach for its announcements"""
olema.com,uses,BioSpace,Page states Olema uses BioSpace as a financial news service/channel to distribute announcements.,https://matrixbcg.com/products/olema-business-model-canvas,"""utilizes prominent financial news services like GlobeNewswire and BioSpace to ensure broad reach for its announcements"""
olema.com,partner_of,Jefferies,Page says Olema participates in Jefferies Global Healthcare Conference as an investor relations channel/event to engage investors and analysts.,https://matrixbcg.com/products/olema-business-model-canvas,"""Participation in key industry events, such as the Jefferies, Evercore, and Citi's Global Healthcare Conferences"""
olema.com,partner_of,Evercore,Page says Olema participates in Evercore healthcare conference as an investor relations channel/event.,https://matrixbcg.com/products/olema-business-model-canvas,"""Participation in key industry events, such as the Jefferies, Evercore, and Citi's Global Healthcare Conferences"""
olema.com,partner_of,Citi,Page says Olema participates in Citi's Global Healthcare Conference as an investor relations channel/event.,https://matrixbcg.com/products/olema-business-model-canvas,"""Participation in key industry events, such as the Jefferies, Evercore, and Citi's Global Healthcare Conferences"""
olema.com,partner_of,Aurigene,"Page cites a $5.0M milestone payment in Q1 2024 linked to Olema’s agreement with Aurigene, indicating a partnership agreement with milestone payments.",https://matrixbcg.com/products/olema-business-model-canvas,"""Olema Oncology reported a $5.0 million milestone payment in the first quarter of 2024, linked to their agreement with Aurigene."""
olema.com,partner_of,Aluma Technologies,"The investigated page is Aluma’s 'Aluma partnership program' page describing a partner program (technology resellers, solution providers/BPOs, commercial resellers, referral partners). This indicates Olema could become a partner, but the page does not name Olema specifically; relationship is inferred only as a potential opportunity, not an explicit relationship.",https://aluma.io/partners,"""Aluma partnership program"" ... ""Join today and we will provide you with the tools, support and guidance to integrate, sell and deliver"" ... ""Types of partnership"""
olema.com,partner_of,CITI Program,"LinkedIn profile shows Karen Paese (Olema Oncology) holds certifications issued by CITI Program, implying Olema personnel use/engage with CITI Program training/certifications.",https://www.linkedin.com/in/karen-paese-7aa1b85,“Licenses & Certifications … FDA Inspections: From Site Preparation to Response — CITI Program … Good Manufacturing Practices (GMP) — CITI Program”
olema.com,partner_of,Santa Clara University - Leavey School of Business,"LinkedIn profile lists Santa Clara University - Leavey School of Business in Karen Paese’s education/affiliation alongside Olema Oncology, indicating an institutional relationship via employee education.",https://www.linkedin.com/in/karen-paese-7aa1b85,“Olema Oncology Santa Clara University - Leavey School of Business”
olema.com,partner_of,Thread,"4G Clinical partnership page states 4G Clinical and Thread are committed to integrated decentralized clinical trial (DCT) workflows; as Olema runs clinical trials, this indicates a potential eClinical partner relationship for sponsors using 4G Clinical/Thread integrated workflows.",https://www.4gclinical.com/partnerships,“4G Clinical and THREAD are committed to bringing a seamless patient experience to decentralized clinical trials through integrated DCT workflows. Our partnership combines our industry-leading platforms…”
olema.com,uses,Amazon Web Services (AWS),"4G Clinical states its Prancer RTSM and 4C Supply platforms run on AWS and that it is an AWS Partner Network Advanced Technology Partner; if Olema uses 4G Clinical platforms for trials, it would indirectly use AWS-backed infrastructure.",https://www.4gclinical.com/partnerships,“4G Clinical’s Prancer RTSM® and 4C Supply® are fully managed platforms that run on AWS… 4G Clinical is an AWS Partner Network (APN) Advanced Technology Partner.”
olema.com,partner_of,Berlinger,4G Clinical describes a strategic partnership with Berlinger to offer automated real-time supply chain track & trace solutions for clinical trials; relevant as a potential partner in Olema’s clinical supply chain ecosystem when using 4G Clinical.,https://www.4gclinical.com/partnerships,"“4G Clinical takes great pride in its collaboration with Berlinger. Through this strategic partnership, 4G Clinical and Berlinger collectively offer cutting-edge Automated Real-Time Supply Chain Track & Trace Solutions.”"
olema.com,partner_of,Society for Clinical Research Sites (SCRS),"4G Clinical states it is a Global Impact Partner with SCRS; for Olema, this indicates an industry stakeholder relationship that may impact site advocacy and trial execution if engaging with 4G Clinical.",https://www.4gclinical.com/partnerships,“4G Clinical proudly serves as a Global Impact Partner with the Society for Clinical Research Sites (SCRS)…”
